Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. markets closed

S&P 500
5,969.34
+20.63(+0.35%)
Dow 30
44,296.51
+426.11(+0.97%)
Nasdaq
19,003.65
+31.25(+0.16%)
Russell 2000
2,406.67
+42.65(+1.80%)
Crude Oil
71.18
-0.06(-0.08%)
Gold
2,718.20
+6.00(+0.22%)

NeuroBo Pharmaceuticals, Inc. (NRBO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

2.3700

-0.0100

(-0.42%)

At close: 04:00PM EST

2.5000

+0.13

(+5.49%)

After hours:

07:56PM EST

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	20.42M
Enterprise Value	-1.10M
Trailing P/E	16.63
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	N/A
Price/Book (mrq)	1.58
Enterprise Value/Revenue	N/A
Enterprise Value/EBITDA	-0.43

Trading Information

Stock Price History

Beta (5Y Monthly)	-0.28
52-Week Change ³	-29.80%
S&P500 52-Week Change ³	31.18%
52 Week High ³	6.7500
52 Week Low ³	2.0800
50-Day Moving Average ³	2.7972
200-Day Moving Average ³	3.8423

Share Statistics

Avg Vol (3 month) ³	44.53k
Avg Vol (10 day) ³	37.96k
Shares Outstanding ⁵	8.62M
Implied Shares Outstanding ⁶	8.62M
Float ⁸	2.1M
% Held by Insiders ¹	65.24%
% Held by Institutions ¹	12.71%
Shares Short (Oct 31, 2024) ⁴	19.2k
Short Ratio (Oct 31, 2024) ⁴	0.38
Short % of Float (Oct 31, 2024) ⁴	0.62%
Short % of Shares Outstanding (Oct 31, 2024) ⁴	0.23%
Shares Short (prior month Sep 30, 2024) ⁴	32.44k

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	Dec 31, 2019
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	1:8
Last Split Date ³	Dec 21, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Sep 30, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	0.00%

Management Effectiveness

Return on Assets (ttm)	-74.35%
Return on Equity (ttm)	-160.76%

Income Statement

Revenue (ttm)	N/A
Revenue Per Share (ttm)	N/A
Quarterly Revenue Growth (yoy)	N/A
Gross Profit (ttm)	N/A
EBITDA	-28.87M
Net Income Avi to Common (ttm)	-27.73M
Diluted EPS (ttm)	-4.2900
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	21.67M
Total Cash Per Share (mrq)	2.52
Total Debt (mrq)	154k
Total Debt/Equity (mrq)	1.19%
Current Ratio (mrq)	2.41
Book Value Per Share (mrq)	1.50

Cash Flow Statement

Operating Cash Flow (ttm)	N/A
Levered Free Cash Flow (ttm)	N/A